GlassScriptPhysician profile
William D Mauch
NPI 1114903424
$2,449.85
in general payments reported to CMS, 2019-2025
32 companies · $496 in 2025
The $496 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $165 · 2021: $143 · 2022: $577 · 2023: $434 · 2024: $376 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $409.26 | 2019-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $320.64 | 2019-2025 | Xtandi |
| Abbvie INC. | $215.96 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $136.71 | 2019-2023 | Provenge |
| Procept Biorobotics Corporation | $121.99 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Pfizer INC. | $118.95 | 2022-2025 | |
| Boston Scientific Corporation | $94.70 | 2020-2025 | Rezum Generator, Axonics |
| Ambu INC. | $82.09 | 2024-2025 | |
| Axonics, INC. | $69.51 | 2023-2024 | Bulkamid, Axonics |
| Progenics Pharmaceuticals, INC. | $67.85 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $65.74 | 2023-2024 | Gemtesa, Orgovyx |
| Janssen Scientific Affairs, LLC | $64.81 | 2019 | |
| Teleflex LLC | $60.76 | 2022-2025 | Barrigel, Urolift |
| Endo USA, INC. | $57.48 | 2024-2025 | Xiaflex |
| Convatec INC. | $55.23 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $50.57 | 2022-2024 | |
| 180 Medical, INC. | $50.19 | 2024-2025 | |
| Olympus America INC. | $50.07 | 2022-2024 | Itind System |
| Allergan, INC. | $49.02 | 2020-2021 | |
| Medtronic, INC. | $45.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.77 | 2021-2022 | |
| Travere Therapeutics, INC. | $33.40 | 2019 | |
| Immunitybio, INC. | $29.91 | 2025 | |
| Ge Healthcare | $19.01 | 2022 | |
| Calyxo, INC. | $18.94 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $18.18 | 2023 | |
| Myovant Sciences INC. | $17.92 | 2021 | |
| Karl Storz Endoscopy-America | $17.66 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $16.72 | 2022 | |
| Coloplast Corp | $16.26 | 2025 | |
| Urovant Sciences INC | $15.64 | 2022 | |
| Myriad Genetic Laboratories, INC. | $15.09 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mauch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.